{"id":309276,"date":"2026-10-15T09:37:46","date_gmt":"2026-10-15T04:07:46","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=309276"},"modified":"2026-10-15T09:37:46","modified_gmt":"2026-10-15T04:07:46","slug":"caplipoint-best-stock-in-its-sector","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/caplipoint-best-stock-in-its-sector\/","title":{"rendered":"Is Caplin Point Laboratories the Best Stock in Its Sector? A Look at the Numbers"},"content":{"rendered":"<p style=\"border-left:4px solid #1F4E79;background:#EBF3FB;padding:10px 16px;font-style:italic;\"><em>Caplin Point Laboratories CMP Rs 2,338 (15 Oct 2026). Market cap Rs 17,764 Cr. ROE 17.88%. P\/E 26.20x versus Industry P\/E 36.77x.<\/em><\/p>\n<div style=\"background:#F0F9FF;border-left:4px solid #2E7D32;border-radius:6px;padding:14px 18px;margin:18px 0;\">\n<p style=\"margin:0;color:#1F4E79;font-size:14px;\"><strong>Quick Answer<\/strong><\/p>\n<p style=\"margin:8px 0 0;\">Caplin Point Laboratories is one of the names investors compare when screening the Healthcare sector, built on a 17.88% return on equity and a P\/E of 26.20x against an Industry P\/E of 36.77x. Whether Caplin Point Laboratories is the best stock in its sector depends on whether an investor is optimising for return ratios, valuation, or both. This article breaks down the metrics, including a comparison against named Healthcare sector peers, so you can judge that for yourself.<\/p>\n<\/p><\/div>\n<p>Is <a href=\"https:\/\/univest.in\/stocks\/caplipoint\/caplin-point-laboratories-ltd-share-price-today\">Caplin Point Laboratories<\/a> the best stock in its sector? The stock trades on the NSE at Rs 2,338 as of 15 October 2026, within its 52-week range of Rs 1,500.30 to Rs 2,990.00. Caplin Point Laboratories Ltd, based in Chennai, is a pharmaceutical company that makes and markets generic formulations, with a strong presence in Latin America and francophone Africa.<\/p>\n<p>Caplin Point Laboratories sits in the Healthcare sector, and its 17.88% ROE and 26.20x P\/E give a starting point for judging where it stands against comparable listed names. The rest of this article compares those numbers against verified peers and the sector&#8217;s Industry P\/E benchmark.<\/p>\n<p style=\"font-style:italic;color:#000000;margin:14px 0;\">Also read &#8211; <a href=\"https:\/\/univest.in\/blogs\/abbott-india-best-stock-in-its-sector\">Is Abbott India the Best Stock in Its Sector? A Look at the Numbers<\/a><\/p>\n<p style=\"margin-top:24px;\"><a href=\"https:\/\/univest.in\/user\/log-in?utm_source=blogs&#038;utm_medium=caplipoint-best-stock-in-its-sector\"><strong>Click Here &#8211; Get Free Investment Predictions<\/strong><\/a><\/p>\n<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_65 counter-hierarchy ez-toc-counter ez-toc-grey ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<p class=\"ez-toc-title \" >Table of Contents<\/p>\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"Toggle Table of Content\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Toggle<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewBox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewBox=\"0 0 24 24\" version=\"1.2\" baseProfile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1 ' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/univest.in\/blogs-2\/caplipoint-best-stock-in-its-sector\/#About_Caplin_Point_Laboratories\" title=\"About Caplin Point Laboratories\">About Caplin Point Laboratories<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/univest.in\/blogs-2\/caplipoint-best-stock-in-its-sector\/#Is_Caplin_Point_Laboratories_the_Best_Stock_in_Its_Sector\" title=\"Is Caplin Point Laboratories the Best Stock in Its Sector?\">Is Caplin Point Laboratories the Best Stock in Its Sector?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/univest.in\/blogs-2\/caplipoint-best-stock-in-its-sector\/#How_Caplin_Point_Laboratories_Compares_Against_Its_Healthcare_Sector_Peers\" title=\"How Caplin Point Laboratories Compares Against Its Healthcare Sector Peers\">How Caplin Point Laboratories Compares Against Its Healthcare Sector Peers<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/univest.in\/blogs-2\/caplipoint-best-stock-in-its-sector\/#What_Makes_Caplin_Point_Laboratories_Worth_Watching_in_Healthcare\" title=\"What Makes Caplin Point Laboratories Worth Watching in Healthcare\">What Makes Caplin Point Laboratories Worth Watching in Healthcare<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/univest.in\/blogs-2\/caplipoint-best-stock-in-its-sector\/#Caplin_Point_Laboratories_Valuation_Is_It_Justified\" title=\"Caplin Point Laboratories Valuation: Is It Justified?\">Caplin Point Laboratories Valuation: Is It Justified?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/univest.in\/blogs-2\/caplipoint-best-stock-in-its-sector\/#How_to_Track_Caplin_Point_Laboratories_Before_You_Invest\" title=\"How to Track Caplin Point Laboratories Before You Invest\">How to Track Caplin Point Laboratories Before You Invest<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-7\" href=\"https:\/\/univest.in\/blogs-2\/caplipoint-best-stock-in-its-sector\/#Conclusion\" title=\"Conclusion\">Conclusion<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-8\" href=\"https:\/\/univest.in\/blogs-2\/caplipoint-best-stock-in-its-sector\/#Is_Caplin_Point_Laboratories_the_best_stock_in_its_sector\" title=\"Is Caplin Point Laboratories the best stock in its sector?\">Is Caplin Point Laboratories the best stock in its sector?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-9\" href=\"https:\/\/univest.in\/blogs-2\/caplipoint-best-stock-in-its-sector\/#What_is_the_current_share_price_of_Caplin_Point_Laboratories\" title=\"What is the current share price of Caplin Point Laboratories?\">What is the current share price of Caplin Point Laboratories?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-10\" href=\"https:\/\/univest.in\/blogs-2\/caplipoint-best-stock-in-its-sector\/#What_sector_does_Caplin_Point_Laboratories_belong_to\" title=\"What sector does Caplin Point Laboratories belong to?\">What sector does Caplin Point Laboratories belong to?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-11\" href=\"https:\/\/univest.in\/blogs-2\/caplipoint-best-stock-in-its-sector\/#How_does_Caplin_Point_Laboratories_compare_to_its_sector_peers_on_PE\" title=\"How does Caplin Point Laboratories compare to its sector peers on P\/E?\">How does Caplin Point Laboratories compare to its sector peers on P\/E?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-12\" href=\"https:\/\/univest.in\/blogs-2\/caplipoint-best-stock-in-its-sector\/#What_is_Caplin_Point_Laboratories_return_on_equity\" title=\"What is Caplin Point Laboratories&#8217; return on equity?\">What is Caplin Point Laboratories&#8217; return on equity?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-13\" href=\"https:\/\/univest.in\/blogs-2\/caplipoint-best-stock-in-its-sector\/#Should_I_invest_in_Caplin_Point_Laboratories_based_on_its_sector_position\" title=\"Should I invest in Caplin Point Laboratories based on its sector position?\">Should I invest in Caplin Point Laboratories based on its sector position?<\/a><\/li><\/ul><\/li><\/ul><\/nav><\/div>\n<h2><span class=\"ez-toc-section\" id=\"About_Caplin_Point_Laboratories\"><\/span><strong>About Caplin Point Laboratories<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Caplin Point Laboratories Ltd, based in Chennai, is a pharmaceutical company that makes and markets generic formulations, with a strong presence in Latin America and francophone Africa. It also makes sterile injectables for regulated markets through its subsidiary Caplin Steriles. The stock trades about 22 percent below its 52-week high and about 56 percent above its 52-week low. At a market capitalisation of Rs 17,764 Cr, it is tracked as part of the Healthcare sector on Univest.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Is_Caplin_Point_Laboratories_the_Best_Stock_in_Its_Sector\"><\/span><strong>Is Caplin Point Laboratories the Best Stock in Its Sector?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Caplin Point Laboratories makes its case as the best stock in its sector primarily on valuation relative to its Industry P\/E, combining a 17.88% ROE with a 26.20x P\/E against the sector&#8217;s 36.77x Industry P\/E. Caplin Point Laboratories&#8217; 26.20x P\/E is below the 36.77x Industry P\/E, Ajanta Pharma at 36.31x and Ipca Laboratories at 35.31x, while its 17.88% ROE is lower than Ajanta Pharma at 23.33%, though higher than Ipca Laboratories at 14.15%, and its debt to equity ratio of 0.00 is below Ajanta Pharma at 0.06 and Ipca Laboratories at 0.10.<\/p>\n<table style=\"width:100%;border-collapse:collapse;\">\n<tr>\n<th style=\"border:1px solid #ddd;padding:8px;text-align:left;\">Metric<\/th>\n<th style=\"border:1px solid #ddd;padding:8px;text-align:left;\">Caplin Point Laboratories<\/th>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #ddd;padding:8px;\">CMP (NSE)<\/td>\n<td style=\"border:1px solid #ddd;padding:8px;\">Rs 2,338.20<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #ddd;padding:8px;\">52-Week High \/ Low<\/td>\n<td style=\"border:1px solid #ddd;padding:8px;\">Rs 2,990.00 \/ Rs 1,500.30<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #ddd;padding:8px;\">Market Cap<\/td>\n<td style=\"border:1px solid #ddd;padding:8px;\">Rs 17,764 Cr<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #ddd;padding:8px;\">P\/E (TTM) vs Industry P\/E<\/td>\n<td style=\"border:1px solid #ddd;padding:8px;\">26.20x vs 36.77x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #ddd;padding:8px;\">P\/B<\/td>\n<td style=\"border:1px solid #ddd;padding:8px;\">5.27<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #ddd;padding:8px;\">ROE<\/td>\n<td style=\"border:1px solid #ddd;padding:8px;\">17.88%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #ddd;padding:8px;\">EPS (TTM)<\/td>\n<td style=\"border:1px solid #ddd;padding:8px;\">Rs 89.20<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #ddd;padding:8px;\">Dividend Yield<\/td>\n<td style=\"border:1px solid #ddd;padding:8px;\">0.34%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #ddd;padding:8px;\">Debt to Equity<\/td>\n<td style=\"border:1px solid #ddd;padding:8px;\">0.00<\/td>\n<\/tr>\n<\/table>\n<p style=\"margin-top:24px;\"><a href=\"https:\/\/univest.in\/screeners\"><strong>Compare Caplin Point Laboratories Against Other Healthcare Sector Stocks<\/strong><\/a><\/p>\n<h2><span class=\"ez-toc-section\" id=\"How_Caplin_Point_Laboratories_Compares_Against_Its_Healthcare_Sector_Peers\"><\/span><strong>How Caplin Point Laboratories Compares Against Its Healthcare Sector Peers<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>The table below sets Caplin Point Laboratories against 2 other Healthcare sector names, using the same live data source for every company. A peer average row is included for P\/E, ROE and debt to equity, calculated across the 2 peer companies.<\/p>\n<table style=\"width:100%;border-collapse:collapse;\">\n<tr>\n<th style=\"border:1px solid #ddd;padding:8px;text-align:left;\">Company<\/th>\n<th style=\"border:1px solid #ddd;padding:8px;text-align:left;\">Market Cap (Rs Cr)<\/th>\n<th style=\"border:1px solid #ddd;padding:8px;text-align:left;\">P\/E<\/th>\n<th style=\"border:1px solid #ddd;padding:8px;text-align:left;\">ROE<\/th>\n<th style=\"border:1px solid #ddd;padding:8px;text-align:left;\">Debt to Equity<\/th>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #ddd;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/caplipoint\/caplin-point-laboratories-ltd-share-price-today\">Caplin Point Laboratories<\/a><\/td>\n<td style=\"border:1px solid #ddd;padding:8px;\">17,764<\/td>\n<td style=\"border:1px solid #ddd;padding:8px;\">26.20<\/td>\n<td style=\"border:1px solid #ddd;padding:8px;\">17.88%<\/td>\n<td style=\"border:1px solid #ddd;padding:8px;\">0.00<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #ddd;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/ajantpharm\/ajanta-pharma-ltd-share-price-today\">Ajanta Pharma<\/a><\/td>\n<td style=\"border:1px solid #ddd;padding:8px;\">41,211<\/td>\n<td style=\"border:1px solid #ddd;padding:8px;\">36.31<\/td>\n<td style=\"border:1px solid #ddd;padding:8px;\">23.33%<\/td>\n<td style=\"border:1px solid #ddd;padding:8px;\">0.06<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #ddd;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/ipcalab\/ipca-laboratories-ltd-share-price-today\">Ipca Laboratories<\/a><\/td>\n<td style=\"border:1px solid #ddd;padding:8px;\">48,550<\/td>\n<td style=\"border:1px solid #ddd;padding:8px;\">35.31<\/td>\n<td style=\"border:1px solid #ddd;padding:8px;\">14.15%<\/td>\n<td style=\"border:1px solid #ddd;padding:8px;\">0.10<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #ddd;padding:8px;\"><strong>Peer average (2 companies)<\/strong><\/td>\n<td style=\"border:1px solid #ddd;padding:8px;\">&#8211;<\/td>\n<td style=\"border:1px solid #ddd;padding:8px;\"><strong>35.81<\/strong><\/td>\n<td style=\"border:1px solid #ddd;padding:8px;\"><strong>18.74%<\/strong><\/td>\n<td style=\"border:1px solid #ddd;padding:8px;\"><strong>0.08<\/strong><\/td>\n<\/tr>\n<\/table>\n<p>Against this peer set, Caplin Point Laboratories&#8217; 17.88% ROE is below the 18.74% peer average, and its P\/E of 26.20x runs below the peer average of 35.81x. Caplin Point Laboratories&#8217; 26.20x P\/E is below the 36.77x Industry P\/E, Ajanta Pharma at 36.31x and Ipca Laboratories at 35.31x, while its 17.88% ROE is lower than Ajanta Pharma at 23.33%, though higher than Ipca Laboratories at 14.15%, and its debt to equity ratio of 0.00 is below Ajanta Pharma at 0.06 and Ipca Laboratories at 0.10.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"What_Makes_Caplin_Point_Laboratories_Worth_Watching_in_Healthcare\"><\/span><strong>What Makes Caplin Point Laboratories Worth Watching in Healthcare<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<ul>\n<li><strong>Valuation:<\/strong> A 26.20x P\/E is below the 36.77x Industry P\/E, Ajanta Pharma at 36.31x and Ipca Laboratories at 35.31x.<\/li>\n<li><strong>Returns:<\/strong> A 17.88% ROE is lower than Ajanta Pharma at 23.33%, though higher than Ipca Laboratories at 14.15%.<\/li>\n<li><strong>Leverage:<\/strong> A debt to equity ratio of 0.00 is below Ajanta Pharma at 0.06 and Ipca Laboratories at 0.10.<\/li>\n<\/ul>\n<h2><span class=\"ez-toc-section\" id=\"Caplin_Point_Laboratories_Valuation_Is_It_Justified\"><\/span><strong>Caplin Point Laboratories Valuation: Is It Justified?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Caplin Point Laboratories&#8217; 26.20x P\/E is below the 36.77x Industry P\/E, Ajanta Pharma at 36.31x and Ipca Laboratories at 35.31x, while its 17.88% ROE is lower than Ajanta Pharma at 23.33%, though higher than Ipca Laboratories at 14.15%, and its debt to equity ratio of 0.00 is below Ajanta Pharma at 0.06 and Ipca Laboratories at 0.10. As with any single stock, investors should weigh this against their own valuation discipline and risk appetite rather than the sector label alone.<\/p>\n<p style=\"font-style:italic;color:#000000;margin:14px 0;\">Also read &#8211; <a href=\"https:\/\/univest.in\/blogs\/ofss-best-stock-in-its-sector\">Is Oracle Financial Services Software the Best Stock in Its Sector? A Look at the Numbers<\/a><\/p>\n<p style=\"margin-top:24px;\"><em>Download the <a href=\"https:\/\/apps.apple.com\/in\/app\/univest-stocks-investment\/id6443753518\" rel=\"nofollow noopener\" target=\"_blank\">Univest iOS App<\/a> or <a href=\"https:\/\/play.google.com\/store\/apps\/details?id=com.univest.capp&#038;hl=en_IN\" rel=\"nofollow noopener\" target=\"_blank\">Univest Android App<\/a> to track Caplin Point Laboratories and other Healthcare sector stocks.<\/em><\/p>\n<h2><span class=\"ez-toc-section\" id=\"How_to_Track_Caplin_Point_Laboratories_Before_You_Invest\"><\/span><strong>How to Track Caplin Point Laboratories Before You Invest<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Before deciding whether Caplin Point Laboratories deserves its label as the best stock in its sector for your own portfolio, compare it directly against Healthcare sector peers using the steps below.<\/p>\n<ol>\n<li>Open the Univest Screener and search for Caplin Point Laboratories to view live price, valuation ratios, and peer comparisons within the Healthcare sector.<\/li>\n<li>Compare its P\/E, P\/B, and ROE against other Healthcare sector stocks before deciding if the current valuation fits your strategy.<\/li>\n<li>Set a price alert around key support and resistance zones using the Univest app so you are notified of meaningful moves.<\/li>\n<li>Open a broking account on Univest if you decide to add the stock, and size the position based on your own risk appetite and portfolio allocation.<\/li>\n<\/ol>\n<h2><span class=\"ez-toc-section\" id=\"Conclusion\"><\/span><strong>Conclusion<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Caplin Point Laboratories earns a place in the best stock in its sector conversation on the strength of a 17.88% ROE and a P\/E of 26.20x against a 36.77x Industry P\/E, with named peer comparisons in this article backing up that picture. As with any individual stock decision, this analysis is educational and investors should do their own research or consult a SEBI-registered advisor before investing.<\/p>\n<div style=\"background:#CC0000;border-radius:8px;padding:16px 20px;margin:24px 0;\">\n<p style=\"color:#FFFFFF;font-size:13px;line-height:1.7;margin:0;\"><strong style=\"color:#FFFFFF;\">Disclaimer:<\/strong> Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).<\/p>\n<\/p><\/div>\n<h3><span class=\"ez-toc-section\" id=\"Is_Caplin_Point_Laboratories_the_best_stock_in_its_sector\"><\/span><strong>Is Caplin Point Laboratories the best stock in its sector?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> There is no single definitive answer, because the best stock in a sector depends on whether an investor is prioritising returns, valuation or balance sheet strength. Caplin Point Laboratories has a 17.88% ROE and trades at 26.20x P\/E against a 36.77x Industry P\/E. Against the 2 peers compared in this article, its ROE is below the 18.74% peer average and its P\/E is below the 35.81x peer average. Its debt to equity ratio of 0.00 is below the 0.08 peer average, which matters because borrowing can inflate returns and add risk when business conditions weaken. These figures are best read together rather than in isolation, and they work as a starting point for your own research and not as a verdict.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_is_the_current_share_price_of_Caplin_Point_Laboratories\"><\/span><strong>What is the current share price of Caplin Point Laboratories?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Caplin Point Laboratories was trading at Rs 2,338.20 on the NSE as of 15 October 2026, within its 52-week range of Rs 1,500.30 to Rs 2,990.00. The stock trades about 22 percent below its 52-week high and about 56 percent above its 52-week low. Its market capitalisation is Rs 17,764 Cr and its EPS (TTM) is Rs 89.20, which is the earnings figure behind the 26.20x P\/E. Share prices change through the trading day, so check the live quote on Univest before acting on any number here.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_sector_does_Caplin_Point_Laboratories_belong_to\"><\/span><strong>What sector does Caplin Point Laboratories belong to?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Caplin Point Laboratories is classified under the Healthcare sector on Univest, and that group of listed companies is the reference point for the 36.77x Industry P\/E used in this article. The 2 named peers compared here are Ajanta Pharma and Ipca Laboratories, chosen as comparable listed names so that the P\/E, ROE and debt figures come from the same live data source. Investors who want a wider view can compare more Healthcare sector stocks on the Univest Screener.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"How_does_Caplin_Point_Laboratories_compare_to_its_sector_peers_on_PE\"><\/span><strong>How does Caplin Point Laboratories compare to its sector peers on P\/E?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Caplin Point Laboratories&#8217; P\/E of 26.20x is below the 35.81x average of the 2 named peers, with Ajanta Pharma at 36.31x and Ipca Laboratories at 35.31x. It also sits below the 36.77x Industry P\/E, which is the benchmark for the wider Healthcare sector. A P\/E that is below a peer average can reflect a valuation discount or premium, but it can also reflect different growth or return expectations, so it should be read alongside ROE and debt. Its P\/B ratio of 5.27 gives one more view of how the market values its book value.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_is_Caplin_Point_Laboratories_return_on_equity\"><\/span><strong>What is Caplin Point Laboratories&#8217; return on equity?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Caplin Point Laboratories reported a return on equity of 17.88%, which is below the 18.74% average of its named peers, with Ajanta Pharma at 23.33% and Ipca Laboratories at 14.15%. ROE shows how much profit a company generates on every rupee of shareholders&#8217; equity, so a higher figure generally points to more efficient use of capital. ROE is easier to trust when leverage is modest, and here the debt to equity ratio is 0.00 against a peer average of 0.08. It is worth checking whether the ROE has been stable over several years rather than relying on a single reading.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Should_I_invest_in_Caplin_Point_Laboratories_based_on_its_sector_position\"><\/span><strong>Should I invest in Caplin Point Laboratories based on its sector position?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Sector position is only one input into an investment decision. Caplin Point Laboratories has a 17.88% ROE and a 26.20x P\/E, which make it worth researching further, and its dividend yield is 0.34%. You should also weigh its business outlook, earnings consistency, debt levels, your investment horizon and your own risk appetite before buying. Spreading money across several stocks and sectors reduces concentration risk, and this article is educational content, not investment advice. For personalised guidance, consult a SEBI-registered advisor.<\/p>\n<div class=\"faq-schema\"><script type=\"application\/ld+json\">{\"@context\":\"https:\/\/schema.org\",\"@type\":\"FAQPage\",\"mainEntity\":[{\"@type\":\"Question\",\"name\":\"Is Caplin Point Laboratories the best stock in its sector?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"There is no single definitive answer, because the best stock in a sector depends on whether an investor is prioritising returns, valuation or balance sheet strength. Caplin Point Laboratories has a 17.88% ROE and trades at 26.20x P\/E against a 36.77x Industry P\/E. Against the 2 peers compared in this article, its ROE is below the 18.74% peer average and its P\/E is below the 35.81x peer average. Its debt to equity ratio of 0.00 is below the 0.08 peer average, which matters because borrowing can inflate returns and add risk when business conditions weaken. These figures are best read together rather than in isolation, and they work as a starting point for your own research and not as a verdict.\"}},{\"@type\":\"Question\",\"name\":\"What is the current share price of Caplin Point Laboratories?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Caplin Point Laboratories was trading at Rs 2,338.20 on the NSE as of 15 October 2026, within its 52-week range of Rs 1,500.30 to Rs 2,990.00. The stock trades about 22 percent below its 52-week high and about 56 percent above its 52-week low. Its market capitalisation is Rs 17,764 Cr and its EPS (TTM) is Rs 89.20, which is the earnings figure behind the 26.20x P\/E. Share prices change through the trading day, so check the live quote on Univest before acting on any number here.\"}},{\"@type\":\"Question\",\"name\":\"What sector does Caplin Point Laboratories belong to?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Caplin Point Laboratories is classified under the Healthcare sector on Univest, and that group of listed companies is the reference point for the 36.77x Industry P\/E used in this article. The 2 named peers compared here are Ajanta Pharma and Ipca Laboratories, chosen as comparable listed names so that the P\/E, ROE and debt figures come from the same live data source. Investors who want a wider view can compare more Healthcare sector stocks on the Univest Screener.\"}},{\"@type\":\"Question\",\"name\":\"How does Caplin Point Laboratories compare to its sector peers on P\/E?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Caplin Point Laboratories' P\/E of 26.20x is below the 35.81x average of the 2 named peers, with Ajanta Pharma at 36.31x and Ipca Laboratories at 35.31x. It also sits below the 36.77x Industry P\/E, which is the benchmark for the wider Healthcare sector. A P\/E that is below a peer average can reflect a valuation discount or premium, but it can also reflect different growth or return expectations, so it should be read alongside ROE and debt. Its P\/B ratio of 5.27 gives one more view of how the market values its book value.\"}},{\"@type\":\"Question\",\"name\":\"What is Caplin Point Laboratories' return on equity?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Caplin Point Laboratories reported a return on equity of 17.88%, which is below the 18.74% average of its named peers, with Ajanta Pharma at 23.33% and Ipca Laboratories at 14.15%. ROE shows how much profit a company generates on every rupee of shareholders' equity, so a higher figure generally points to more efficient use of capital. ROE is easier to trust when leverage is modest, and here the debt to equity ratio is 0.00 against a peer average of 0.08. It is worth checking whether the ROE has been stable over several years rather than relying on a single reading.\"}},{\"@type\":\"Question\",\"name\":\"Should I invest in Caplin Point Laboratories based on its sector position?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Sector position is only one input into an investment decision. Caplin Point Laboratories has a 17.88% ROE and a 26.20x P\/E, which make it worth researching further, and its dividend yield is 0.34%. You should also weigh its business outlook, earnings consistency, debt levels, your investment horizon and your own risk appetite before buying. Spreading money across several stocks and sectors reduces concentration risk, and this article is educational content, not investment advice. For personalised guidance, consult a SEBI-registered advisor.\"}}]}<\/script><\/div>\n","protected":false},"excerpt":{"rendered":"<p>Is Caplin Point Laboratories the best stock in its Healthcare sector? A data-driven comparison against named peers on P\/E, ROE and more.<\/p>\n","protected":false},"author":34,"featured_media":309274,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[24],"tags":[5839,1019],"class_list":["post-309276","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-market","tag-sector-stocks","tag-stock-market"],"metadata":{"rank_math_internal_links_processed":["1"],"_thumbnail_id":["309274"],"rank_math_title":["Is Caplin Point Laboratories the Best Stock in Its Sector? A Look at the Numbers"],"rank_math_description":["Is Caplin Point Laboratories the best stock in its Healthcare sector? A data-driven comparison against named peers on P\/E, ROE and more."],"rank_math_focus_keyword":["Is Caplin Point Laboratories the Best Stock in Its Sector? A Look at the Numbers"],"rank_math_robots":["a:2:{i:0;s:7:\"noindex\";i:1;s:8:\"nofollow\";}"]},"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"https:\/\/univest.in\/blogs-2\/wp-content\/uploads\/2026\/10\/is-caplin-point-laboratories-the-best-stock-in-its-sector-a-look-at-the-numbers.webp","_links":{"self":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/309276","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/users\/34"}],"replies":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/comments?post=309276"}],"version-history":[{"count":1,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/309276\/revisions"}],"predecessor-version":[{"id":309277,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/309276\/revisions\/309277"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media\/309274"}],"wp:attachment":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media?parent=309276"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/categories?post=309276"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/tags?post=309276"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}